Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    ICYMI: Opdivo Now Approved for Patients Aged 12+ with Surgically Resected Stage 2B-C Melanoma

      In the past, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) for different forms of cancer, such as non-small cell lung cancer (NSCLC) and melanoma. More recently,…

    Continue Reading ICYMI: Opdivo Now Approved for Patients Aged 12+ with Surgically Resected Stage 2B-C Melanoma
    Care Assessment Need (CAN) Score Could Improve Care for Veterans with Basal Cell Carcinoma
    Photo by sydney Rae on Unsplash

    Care Assessment Need (CAN) Score Could Improve Care for Veterans with Basal Cell Carcinoma

      Coordinating medical care can be complex, especially when you are older. If you are dealing with a health condition like cancer, you might be wondering: how long can/will I…

    Continue Reading Care Assessment Need (CAN) Score Could Improve Care for Veterans with Basal Cell Carcinoma
    Rare Community Profiles: Destroy Duchenne: How Elijah Stacy is Working to Improve the Lives of People with Duchenne Muscular Dystrophy
    Photo courtesy of Elijah Stacey

    Rare Community Profiles: Destroy Duchenne: How Elijah Stacy is Working to Improve the Lives of People with Duchenne Muscular Dystrophy

    Rare Community Profiles     Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families,…

    Continue Reading Rare Community Profiles: Destroy Duchenne: How Elijah Stacy is Working to Improve the Lives of People with Duchenne Muscular Dystrophy
    Doctors Identify Coding DNA Variants that Could Cause Childhood-Onset Schizophrenia
    Found on Unsplash

    Doctors Identify Coding DNA Variants that Could Cause Childhood-Onset Schizophrenia

    Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

    Continue Reading Doctors Identify Coding DNA Variants that Could Cause Childhood-Onset Schizophrenia